SOURCE: Equity News Circuit

Equity News Circuit

May 01, 2013 08:20 ET

Free Research Reports on CIE, PTIE, THC and XYL Issued by the Paragon Report

Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit

NEW YORK, NY--(Marketwired - May 1, 2013) - The Paragon Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Cobalt International Energy, Inc. (NYSE: CIE) shares declined approximately 3.0 percent Monday after releasing results for the first quarter of 2013. The company reported loss grew to $128.1 million, or $0.31 per share, for the quarter, from a loss of $36.5 million, $0.09 per share, in the year ago quarter.

Find out more about Cobalt International Energy including full access to the free equity report at: www.ParagonReport.com/CIE

Pain Therapeutics, Inc. (NASDAQ: PTIE) shares soared 25 percent on volume of over 2.0 million shares traded Tuesday. The company's partner Pfizer Inc. in a recent conference call stated that it had a productive discussion with the FDA regarding the next steps for the painkiller, Remoxy.

Find out more about Pain Therapeutics including full access to the free equity report at: www.ParagonReport.com/PTIE

Tenet Healthcare Corp. (NYSE: THC) shares spiked $2.68 on more than double the average daily Monday to close at $11.55 a share. Hospital stocks rallied after the U.S. Centers for Medicare and Medicaid Services recommended a 0.8 percent increase to Medicare hospital payments, which was higher than expected.

Find out more about Tenet Healthcare including full access to the free equity report at: www.ParagonReport.com/THC

Xylem Inc. (NYSE: XYL) shares dipped slightly after releasing results for the first quarter of 2013 Tuesday. The company reported a net income of $41 million, or $0.22 per share, for the quarter, a decrease of 35 percent when compared to a net income of $63 million, or $0.34 per share, in the year ago quarter.

Find out more about Xylem including full access to the free equity report at: www.ParagonReport.com/XYL

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information